Skip to content

Motivational Interviewing With Diabetes Patients

Effects of Motivational Interviewing Intervention on Self- Management and HbA1c in Type 2 Diabetes Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05187806
Enrollment
60
Registered
2022-01-12
Start date
2017-02-07
Completion date
2017-12-07
Last updated
2022-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

type 2 diabetes, motivational interviewing, HbA1c, self management

Brief summary

This study was conducted in a quasi-experimental research design with a pretest-posttest control group to determine the effect of motivational interviewing on self-management and HbA1c in patients with type 2 diabetes. The sample of the study consisted of 25 experimental and 26 controls, who applied to an outpatient clinic in a training and research hospital.

Detailed description

This study was conducted in a quasi-experimental research design with a pretest-posttest control group to determine the effect of motivational interviewing on self-management and HbA1c in patients with type 2 diabetes. The sample of the study consisted of 25 experimental and 26 controls, who applied to an outpatient clinic in a training and research hospital. After the pretest, the experimental group was intervened with a motivational interview (MI) method that consisted of four sessions; the control group received routine treatment.

Interventions

BEHAVIORALmotivational interview

After the pretest, the experimental group was intervened with a motivational interview (MI) method that consisted of four sessions.The pretest and posttest Diabetes Self-Management Scale total scores and HbA1c values of the patients in the experimental and control groups were compared.

Sponsors

Istanbul University - Cerrahpasa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Masking description

Without knowing that participants are in the experimental or control group

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years and older * Having been diagnosed with type 2 diabetes for more than 3 months * Being in the contemplation * Preparation, and/or action stages of any section of the Behavioral Change Stage Identification Form of the Trans-Theoretical Model * Having HbA1c levels above 6 * Agreeing to take part in the study

Exclusion criteria

* Having a perception disorder that will prevent communication * Having been diagnosed with any mental disorder

Design outcomes

Primary

MeasureTime frameDescription
Comparison of the pretest-posttest Diabetes Self-management Instrument-35 scores3 monthsThe instrument is comprised of 35 questions covering the period from the previous three months to determine the frequency of the implementation of the self-management skills of the patients. The total score for the Instrument ranged from 35 to 140. A higher score showed that self-management activities were implemented on a more regular basis. Interventions consisted of four sessions of 30-60 (mean 45 min) min each. The sessions were structured according to the Behavior Change Stage Identification Form developed by the researcher by making use of the trans-theoretical model and adapting it to diabetic patients.The discussions were completed in four weeks, with one discussion held every week. The final test and the Diabetes Self-Management Instrument were applied again to the members of the intervention group in the third month after completion of the MI method sessions and in the third month to the control group.

Secondary

MeasureTime frameDescription
Comparison of the pretest-posttest HbA1c values3 monthsThe pretest and posttest HbA1c values of the patients in the experimental and control groups were compared in the third month.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026